Document is current
Any future updates will be listed below
-
Authors
Malard, Florent http://orcid.org/0000-0002-3474-0002
Vekhoff, Anne
Lapusan, Simona
Isnard, Francoise
D’incan-Corda, Evelyne
Rey, Jérôme
Saillard, Colombe
Thomas, Xavier
Ducastelle-Lepretre, Sophie
Paubelle, Etienne
Larcher, Marie-Virginie
Rocher, Clément
Recher, Christian http://orcid.org/0000-0002-3332-4525
Tavitian, Suzanne
Bertoli, Sarah http://orcid.org/0000-0003-1084-2781
Michallet, Anne-Sophie
Gilis, Lila
Peterlin, Pierre
Chevallier, Patrice
Nguyen, Stéphanie
Plantamura, Emilie
Boucinha, Lilia
Gasc, Cyrielle
Michallet, Mauricette
Dore, Joel
Legrand, Ollivier
Mohty, Mohamad
- License Information
-
More Information
Article History
Received: 25 September 2020
Accepted: 22 April 2021
First Online: 25 May 2021
Competing interests
: F.M. reports lecture honoraria from Therakos/Mallinckrodt, Biocodex, Janssen, Keocyt, Sanofi, JAZZ pharmaceuticals and Astellas, all outside the submitted work. J.D. received consultancy honoraria from MaaT Pharma and reports grants and/or lecture honoraria from Janssen, Sanofi, MaaT Pharma, BMS, Nestle, Bridor and Danone. C.R.: Research grants (my institution: CHU de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole): Abbvie, Amgen, Novartis, Celgene, JAZZ pharmaceuticals Agios, Daiichi-Sankyo, Astellas, Sunesis, Roche, MaaT Pharma. Advisory boards: Abbvie, Janssen, Jazz Pharma, Daiichi-Sankyo, Astellas, Novartis, Celgene, Otsuka, Sunesis, Roche, Otsuka, Macrogenics, Pfizer. S.B.: advisory board: Daiichi-Sankyo, Astellas, Jazz Pharma, Sanofi. Emilie Plantamura, Lilia Boucinha and Cyrielle Gasc are MaaT Pharma employees. Mohamad Mohty reports grants and/or lecture honoraria from Janssen, Sanofi, MaaT Pharma, JAZZ pharmaceuticals, Celgene, Amgen, BMS, Takeda, Pfizer, and Roche. The other authors did not disclose any relevant conflict of interest in relation to this work.
